ART2Dose: A comprehensive dose verification platform for online adaptive radiotherapy.
Journal
Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746
Informations de publication
Date de publication:
19 Oct 2023
19 Oct 2023
Historique:
revised:
09
09
2023
received:
29
06
2023
accepted:
07
10
2023
medline:
19
10
2023
pubmed:
19
10
2023
entrez:
19
10
2023
Statut:
aheadofprint
Résumé
Online adaptive radiotherapy (ART) involves the development of adaptable treatment plans that consider patient anatomical data obtained right prior to treatment administration, facilitated by cone-beam computed tomography guided adaptive radiotherapy (CTgART) and magnetic resonance image-guided adaptive radiotherapy (MRgART). To ensure accuracy of these adaptive plans, it is crucial to conduct calculation-based checks and independent verification of volumetric dose distribution, as measurement-based checks are not practical within online workflows. However, the absence of comprehensive, efficient, and highly integrated commercial software for secondary dose verification can impede the time-sensitive nature of online ART procedures. The main aim of this study is to introduce an efficient online quality assurance (QA) platform for online ART, and subsequently evaluate it on Ethos and Unity treatment delivery systems in our clinic. To enhance efficiency and ensure compliance with safety standards in online ART, ART2Dose, a secondary dose verification software, has been developed and integrated into our online QA workflow. This implementation spans all online ART treatments at our institution. The ART2Dose infrastructure comprises four key components: an SQLite database, a dose calculation server, a report generator, and a web portal. Through this infrastructure, file transfer, dose calculation, report generation, and report approval/archival are seamlessly managed, minimizing the need for user input when exporting RT DICOM files and approving the generated QA report. ART2Dose was compared with Mobius3D in pre-clinical evaluations on secondary dose verification for 40 adaptive plans. Additionally, a retrospective investigation was conducted utilizing 1302 CTgART fractions from ten treatment sites and 1278 MRgART fractions from seven treatment sites to evaluate the practical accuracy and efficiency of ART2Dose in routine clinical use. With dedicated infrastructure and an integrated workflow, ART2Dose achieved gamma passing rates that were comparable to or higher than those of Mobius3D. Additionally, it significantly reduced the time required to complete pre-treatment checks by 3-4 min for each plan. In the retrospective analysis of clinical CTgART and MRgART fractions, ART2Dose demonstrated average gamma passing rates of 99.61 ± 0.83% and 97.75 ± 2.54%, respectively, using the 3%/2 mm criteria for region greater than 10% of prescription dose. The average calculation times for CTgART and MRgART were approximately 1 and 2 min, respectively. Overall, the streamlined implementation of ART2Dose notably enhances the online ART workflow, offering reliable and efficient online QA while reducing time pressure in the clinic and minimizing labor-intensive work.
Sections du résumé
BACKGROUND
BACKGROUND
Online adaptive radiotherapy (ART) involves the development of adaptable treatment plans that consider patient anatomical data obtained right prior to treatment administration, facilitated by cone-beam computed tomography guided adaptive radiotherapy (CTgART) and magnetic resonance image-guided adaptive radiotherapy (MRgART). To ensure accuracy of these adaptive plans, it is crucial to conduct calculation-based checks and independent verification of volumetric dose distribution, as measurement-based checks are not practical within online workflows. However, the absence of comprehensive, efficient, and highly integrated commercial software for secondary dose verification can impede the time-sensitive nature of online ART procedures.
PURPOSE
OBJECTIVE
The main aim of this study is to introduce an efficient online quality assurance (QA) platform for online ART, and subsequently evaluate it on Ethos and Unity treatment delivery systems in our clinic.
METHODS
METHODS
To enhance efficiency and ensure compliance with safety standards in online ART, ART2Dose, a secondary dose verification software, has been developed and integrated into our online QA workflow. This implementation spans all online ART treatments at our institution. The ART2Dose infrastructure comprises four key components: an SQLite database, a dose calculation server, a report generator, and a web portal. Through this infrastructure, file transfer, dose calculation, report generation, and report approval/archival are seamlessly managed, minimizing the need for user input when exporting RT DICOM files and approving the generated QA report. ART2Dose was compared with Mobius3D in pre-clinical evaluations on secondary dose verification for 40 adaptive plans. Additionally, a retrospective investigation was conducted utilizing 1302 CTgART fractions from ten treatment sites and 1278 MRgART fractions from seven treatment sites to evaluate the practical accuracy and efficiency of ART2Dose in routine clinical use.
RESULTS
RESULTS
With dedicated infrastructure and an integrated workflow, ART2Dose achieved gamma passing rates that were comparable to or higher than those of Mobius3D. Additionally, it significantly reduced the time required to complete pre-treatment checks by 3-4 min for each plan. In the retrospective analysis of clinical CTgART and MRgART fractions, ART2Dose demonstrated average gamma passing rates of 99.61 ± 0.83% and 97.75 ± 2.54%, respectively, using the 3%/2 mm criteria for region greater than 10% of prescription dose. The average calculation times for CTgART and MRgART were approximately 1 and 2 min, respectively.
CONCLUSION
CONCLUSIONS
Overall, the streamlined implementation of ART2Dose notably enhances the online ART workflow, offering reliable and efficient online QA while reducing time pressure in the clinic and minimizing labor-intensive work.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : R01 CA218402
Pays : United States
Informations de copyright
© 2023 American Association of Physicists in Medicine.
Références
Montalvo SK, Kim N, Nwachukwu C, et al. On the feasibility of improved target coverage without compromising organs at risk using online adaptive stereotactic partial breast irradiation (A-SPBI). J Appl Clin Med Phys. 2023;24(2):e13813.
Sibolt P, Booth J, Aland T, Kidane G, Popple R, Cai B, Evaluation of Calculation-Based Patient Specific QA for Online Adaptive Radiotherapy. https://medicalaffairs.varian.com/Clinical-Notes-Technical-Notes-and-White-Papers2021
Zhu TC, Stathakis S, Clark JR, et al. Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT. Med Phys. 2021;48(10):e808-e829.
Shen C, Chen L, Zhong X, et al. Clinical experience on patient-specific quality assurance for CBCT-based online adaptive treatment plan. J Appl Clin Med Phys. 2023;24(4):e13918.
Stanley DN, Harms J, Pogue JA, et al. A roadmap for implementation of kV-CBCT online adaptive radiation therapy and initial first year experiences. J Appl Clin Med Phys. 2023:e13961.
Kluter S. Technical design and concept of a 0.35 T MR-Linac. Clin Transl Radiat Oncol. 2019;18:98-101.
Price AT, Knutson NC, Kim T, Green OL. Commissioning a secondary dose calculation software for a 0.35 T MR-linac. J Appl Clin Med Phys. 2022;23(3):e13452.
Wang Y, Mazur TR, Park JC, Yang D, Mutic S, Li HH. Development of a fast Monte Carlo dose calculation system for online adaptive radiation therapy quality assurance. Phys Med Biol. 2017;62(12):4970-4990.
Graves SA, Snyder JE, Boczkowski A, et al. Commissioning and performance evaluation of RadCalc for the Elekta unity MRI-linac. J Appl Clin Med Phys. 2019;20(12):54-62.
Tsuneda M, Abe K, Fujita Y, Ikeda Y, Furuyama Y, Uno T. Elekta Unity MR-linac commissioning: mechanical and dosimetry tests. J Radiat Res (Tokyo). 2023;64(1):73-84.
Cheng B, Xu Y, Li S, et al. Development and clinical application of a GPU-based Monte Carlo dose verification module and software for 1.5 T MR-LINAC. Med Phys. 2023;50(5):3172-3183.
Li Y, Wang B, Ding S, et al. Feasibility of using a commercial collapsed cone dose engine for 1.5T MR-LINAC online independent dose verification. Physica Medica. 2020;80:288-296.
Yang J, Zhang P, Tyagi N, et al. Integration of an independent monitor unit check for high-magnetic-field MR-guided radiation therapy system. Front Oncol. 2022;12:747825.
Nachbar M, Monnich D, Dohm O, Friedlein M, Zips D, Thorwarth D. Automatic 3D Monte-Carlo-based secondary dose calculation for online verification of 1.5 T magnetic resonance imaging guided radiotherapy. Phys Imaging Radiat Oncol. 2021;19:6-12.
Li Y, Ding S, Wang B, Liu H, Huang X, Song T. Extension and validation of a GPU-Monte Carlo dose engine gDPM for 1.5 T MR-LINAC online independent dose verification. Med Phys. 2021;48(10):6174-6183.
Chen M, Lai Y, Lin J, et al. Web-based fully automatic 2nd check for online adaptive radiotherapy: beam modeling and auto-commissioning. AAPM Annual Meeting; 2022.
Jia X, Gu XJ, Graves YJ, Folkerts M, Jiang SB. GPU-based fast Monte Carlo simulation for radiotherapy dose calculation. Phys Med Biol. 2011;56(22):7017-7031.
Django. The web framework for perfectionists with deadlines. https://www.djangoproject.com/
Fogliata A, Nicolini G, Clivio A, Vanetti E, Mancosu P, Cozzi L. Dosimetric validation of the Acuros XB Advanced Dose Calculation algorithm: fundamental characterization in water. Phys Med Biol. 2011;56(6):1879-1904.
Fippel M. Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm. Med Phys. 1999;26(8):1466-1475.
Dunn L, Jolly D. Automated data mining of a plan-check database and example application. J Appl Clin Med Phys. 2018;19(5):739-748.
Chen GP, Ahunbay E, Li XA. Technical Note: development and performance of a software tool for quality assurance of online replanning with a conventional Linac or MR-Linac. Med Phys. 2016;43(4):1713.
Lee D, Pavord D, Oh S, Sohn J. An Independent Three-Dimensional (3D) Dose Verification System for Elekta Unity MR-Linac Online Plans. Research Square; 2021. DOI: 10.21203/rs.3.rs-381411/v1